Axogen, Inc. Appoints John H. Johnson to Board of Directors
July 19, 2021 16:01 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., July 19, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to...
Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021
July 14, 2021 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., July 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to...
Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference
May 18, 2021 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to...
Axogen, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
May 06, 2021 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla. , May 06, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity...
Axogen, Inc. Reports 2021 First Quarter Financial Results
May 05, 2021 16:00 ET
|
Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
Axogen, Inc. to Report First Quarter Financial Results and Host Conference Call on May 5, 2021
April 14, 2021 07:00 ET
|
Axogen, Inc.
ALACHUA Fla. and TAMPA, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to...
Axogen, Inc. Promotes Peter J. Mariani to Executive Vice President and Chief Financial Officer
March 01, 2021 16:01 ET
|
Axogen, Inc.
ALACHUA, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
Axogen, Inc. Reports 2020 Fourth Quarter and Full-Year Financial Results
February 22, 2021 16:01 ET
|
Axogen, Inc.
ALACHUA, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported...
Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis
February 18, 2021 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
Axogen, Inc. to Participate at Upcoming February Investor Conferences
February 04, 2021 07:00 ET
|
Axogen, Inc.
ALACHUA, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...